News & Analysis on Clinical Trial Services & Contract Research And Development
Febit has updated its Geniom microRNA analysis platform with the latest version of the Sanger Institute's database of all known miRNA elements. The upgrade should provide scientists with a more detailed microRNA profile of their samples.
An $8.8m collaboration between two pharma companies and a leading university has resulted in a project that uses fragment-based crystallography and in silico fragment screening for lead identification.
Dr Hans Groeger has been appointed to the role of site manager at Roche Carolina's Florence facility.
VisEn Medical has launched a new version of its fluorescence molecular tomography platform for small animal imaging, the FMT 2500.
Eli Lilly plans to cut 500 jobs, mainly in manufacturing, as it attempts to restructure its operations to mitigate against the losses from inhaled insulin.
The US Food and Drug Administration (FDA) believes that the contamination of Baxter's blood thinner heparin, which has been linked to 62 deaths in the US, may have been due to the deliberate replacement of some ingredients with cheaper alternatives.
Pharmaceutical firms operating in Canada could face increasing regulatory pressure if government plans to tighten up consumer protection laws are passed.
The contract manufacturing organisation (CMO) business model needs to change if companies expect to remain competitive in this evolving industry, which is tipped to see tough times ahead.